Research Reports

G1_Dallas achieved record quarterly adjusted EBITDA of $9.1 million in Q1 2026 (COO, CFO).
Gross margins expanded to 17% in Q1, up ~10% from Q4 2025 run rate, on lower throughput of 683 MW (2.7 GW annualized) (CFO).
G2_Austin Phase 1 construction on schedule; first cell production targeted for Q4 2026 (CEO).
G2 Phase 1 planned capital investment of $425 million; remaining CapEx needed approximately $225 million (CEO, CFO).
G2 Phase 1 capacity: 2.1 GW; potential Phase 2 expansion to >5 GW (CEO).
G1_Dallas capacity: 5 GW; workforce >1,200 people (CEO).
Q1 production sales lower sequentially due to customers working down inventory ahead of July safe harbor deadline (COO).
International cell procurement program: 4 vendors completed non-FEOC diligence; number expected to rise (CFO).
Official guidance: 2026 G1 production guidance range unchanged at 3.1 to 4.2 GW; no changes to annual adjusted EBITDA run rate guidance targets for G1 and G2 (CFO).
More detailed 2026 guidance to be issued after clarity on customer demand post-July, potential Section 232 ruling, and IEEPA tax refund outcome (CFO).
April 2026 upsized public convertible senior notes offering generated $176 million of net proceeds (CFO).
Targeting announcement of comprehensive G2 financing package in 2Q 2026 (CEO, CFO).

(CEO) “Construction of the 2.1 gigawatt Phase 1 of G2_Austin is progressing according to schedule.”
(COO) “2026 is off to a solid start as we achieved record quarterly adjusted EBITDA of $9.1 million in Q1.”
(CFO) “The improvement in our margin was primarily due to the favorable mix shift to volumes under cost plus in the 2026 fixed margin offtake contract.”
(CEO) “We invested more than $600 million in G1_Dallas, our world-class 5-gigawatt module facility in Texas.”
(CFO) “The quantum we expect to raise from this financing will be more than sufficient to fund the remaining CapEx of approximately $225 million for Phase 1 of G2_Austin.”

Metric	Value	Speaker/Context
Adjusted EBITDA (Q1 2026)	$9.1 million	COO, CFO
Gross margin (Q1 2026)	17%	CFO
Production throughput (Q1 2026)	683 MW (2.7 GW annualized)	CFO
G2 Phase 1 capacity	2.1 GW	CEO
G1_Dallas capacity	5 GW	CEO
Remaining CapEx for G2 Phase 1	~$225 million	CEO, CFO
G2 Phase 1 total planned capital investment	$425 million	CEO
Net proceeds from April 2026 convertible offering	$176 million	CFO
2026 G1 production guidance range	3.1 – 4.2 GW	CFO
April rainfall in Taylor, TX	10.3 inches (3x normal)	CEO

Topic: 毛利率与232关税对商户电力销售的影响
Key points:
- 1Q毛利率17%，基于2.7GW产量及成本加成或固定毛利合同
- 2026全年低端产量指引3.1GW时，17%毛利率合理；超出低端时毛利率取决于模块价格与成本相对变动
- 232最终规则将影响Hemlock国内多晶硅合同及2026年后效益
Mgmt stance: 中性，需等待232规则明确后才能提供更好2026指引

Topic: 承购合同宣布时序与G1/G2国内含量需求
Key points:
- 重大承购合同将在执行后宣布，不会提前披露条款书
- 本季度将宣布以债务为主的综合融资方案，承购合同与之独立
- 客户询问G1/G2国内含量规模，主要源于AI与超大规模数据中心需求
Mgmt stance: 中性，需求信号强劲但坚持纪律性推进G2全面财务交割

Topic: 45X税收抵免货币化与下半年毛利率
Key points:
- 2025年余额预计近期货币化，2026年税股权伙伴谈判预计3Q至年底
- 超出3GW合同产量后，商户销售毛利率取决于当前0.30美元价格与电池片成本
- 电池片成本同比压缩，库存仅维持约一个季度；玻璃等BOM成本持续优化
Mgmt stance: 中性，232对2027年G2晶圆转换效益更大，今年影响有限

Topic: 232关税框架、非FEOC电池片供应与承购合同
Key points:
- 232预计6月左右发布，可能采用最低进口价格而非百分比形式
- 2026年需填补全部非FEOC电池片缺口，产量指引3.1-4.2GW；2027年G2投产后仍有缺口
- 无需等待232即可签署承购合同，公用事业开发商已知晓国内多晶硅优势
Mgmt stance: 中性，已锁定2026年供应并启动2027年采购，市场保持稳健